| 今开：0.0 | 昨收：30.0 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.00054076E9 |
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-10-20,SVP and General Counsel,Swan Winifred L ,期权,3000普通股, $11.03
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-10-20,SVP and Chief Financial Office,TOWSE MATTHEW W ,卖出,4030普通股, $27.50
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-10-20,SVP and Chief Financial Office,TOWSE MATTHEW W ,期权,4030普通股, $14.05
$NxStage Medical, Inc.(NXTM)$ 8-K - Current report Filed: 2017-10-19 AccNo: 0001333170-17-000019 Size: 20 KBItem 8.01: Other Events 网页链接
$NxStage Medical, Inc.(NXTM)$ 8-K - Current report Filed: 2017-10-06 AccNo: 0001333170-17-000017 Size: 17 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-10-04,总裁,Turk Joseph E Jr ,卖出,1000普通股, $27.56
$NxStage Medical, Inc.(NXTM)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-09-22 AccNo: 0001193125-17-291365 Size: 1 MB 网页链接
$NxStage Medical, Inc.(NXTM)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-09-22 AccNo: 0001193125-17-291365 Size: 1 MB 网页链接
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-09-20,SVP and Chief Financial Office,TOWSE MATTHEW W ,卖出,4300普通股, $27.27
$NxStage Medical, Inc.(NXTM)$ 内部交易: 2017-09-20,SVP and Chief Financial Office,TOWSE MATTHEW W ,期权,4300普通股, $14.05